Diabetics use glucose monitors. Should non-diabetics use them too?
Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...
Click2Houston6d
‘We love this fairly low-risk intervention’: Over-the-counter device is helping people gain insight into their health
Continuous glucose monitors (CGM), once exclusive to diabetics, are now available over-the-counter, opening new possibilities ...
drugdeliverybusiness10d
Trinity Biotech completes pre-pivotal study of next-gen CGM
Trinity Biotech today announced that it completed the first pre-pivotal clinical trial in Europe for its next-generation CGM ...
Medscape7d
CGM With Geriatric Care Simplifies T1D Management in Seniors
Continuous glucose monitoring enhanced by geriatric care principles reduced the duration of hypoglycemia without worsening ...
Abbott Laboratories: Buy Rating Reaffirmed Amid Strong Medical Device Performance and Positive Long-Term Growth Outlook
Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report) and keeping the price ...
Nasdaq13d
Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology
In contrast, Glucotrack seeks to address these shortcomings of contemporary CGM devices. One of the most distinct advantages of the company’s solution is a much longer sensor life. Moreover ...
10 Best Internet of Things (IoT) Stocks to Buy
DexCom, Inc. (NASDAQ:DXCM) has also consistently beat EPS estimates in the last 4 quarters. The stock has received an average ...
Mena FN2d
Continuous Glucose Monitoring Devices Market Projected To Witness Substantial Growth, 2024-2031: Medtronic, Dexcom, Inc.
Continuous Glucose Monitoring Devices Market to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9% between 2024 and 2031 BURLINGAME, CA, UNITED STATES, October 15, 2024 /EINPresswire / -- A ...
Abbott Q3: Strong Growth In Medical Device And Pharma
Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...
Is Abbott Laboratories Stock a Buy?
The case for Abbott Laboratories. Abbott Laboratories is one of the world's leading medical device makers. It routinely ...
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...
The Motley Fool10d
Best Medical Device Stocks to Buy for 2024
The medical device market is set to grow from over $500B to nearly $890B by 2032. Top medical device stocks include Abbott Laboratories and GE Healthcare. Investment options also include medical ...